Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Jiuzhou Fangyuan Pharmaceutical is a Chinese pharmaceutical company headquartered in Bozhou, Anhui Province, a major global hub for Traditional Chinese Medicine (TCM). Established in 2003, the company operates as a comprehensive enterprise integrating the cultivation, processing, and distribution of TCM decoction pieces with the manufacturing of modern chemical drug preparations. Its product portfolio includes various dosage forms such as tablets, capsules, and granules, all produced in GMP-certified facilities. The company primarily focuses on the domestic Chinese market, providing treatments for respiratory ailments, cardiovascular conditions, and general health. Anhui Jiuzhou Fangyuan is recognized for its contribution to the modernization of traditional medicine through standardized manufacturing and quality control processes. The firm leverages the local resources of the Bozhou TCM market to ensure a consistent supply of high-quality raw materials for its diverse product line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Jiuzhou Fangyuan Pharmaceutical.